Avantor (AVTR) Non-Current Deferred Tax Liability (2017 - 2026)
Avantor's (AVTR) quarterly Non-Current Deferred Tax Liability came in at $550.4 million in Q1 2026, little changed year-on-year from $550.0 million in Q1 2025, and down 1.2% quarter-over-quarter from $557.1 million in Q4 2025.
Avantor (AVTR) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends
Avantor's Non-Current Deferred Tax Liability history runs 10 years deep, the most recent figure standing at $550.4 million for Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability changed 0.07% year-over-year to $550.4 million in Q1 2026; TTM through Mar 2026 was $550.4 million, a 0.07% change from a year earlier, with the FY2025 full-year figure at $557.1 million, changed 0.04% from the prior year.
- Non-Current Deferred Tax Liability eased to $550.4 million in Q1 2026 per AVTR's latest filing, from $557.1 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $905.8 million in Q4 2022 and bottomed at $535.7 million in Q2 2025.
- The 5-year median for Non-Current Deferred Tax Liability is $600.6 million (2024), against an average of $639.8 million.
- Across the five-year window, Non-Current Deferred Tax Liability advanced 19.83% in 2022 and plunged 32.35% in 2023, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $905.8 million in 2022, then tumbled by 32.35% to $612.8 million in 2023, then dropped by 9.06% to $557.3 million in 2024, then slipped by 0.04% to $557.1 million in 2025, then decreased by 1.2% to $550.4 million in 2026.
- Per Business Quant, the three latest AVTR Non-Current Deferred Tax Liability figures stand at $550.4 million (Q1 2026), $557.1 million (Q4 2025), and $548.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Avantor | 7.67 Bn | 7.39 Bn | 500.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 550.40 Mn |
| Mar 31, 2026 | 550.40 Mn |
| Dec 31, 2025 | 557.10 Mn |
| Dec 31, 2025 | 557.10 Mn |
| Sep 30, 2025 | 548.50 Mn |
| Sep 30, 2025 | 548.50 Mn |
| Jun 30, 2025 | 535.70 Mn |
| Jun 30, 2025 | 535.70 Mn |
| Mar 31, 2025 | 550.00 Mn |
| Mar 31, 2025 | 550.00 Mn |
| Dec 31, 2024 | 557.30 Mn |
| Dec 31, 2024 | 557.30 Mn |
| Sep 30, 2024 | 547.30 Mn |
| Sep 30, 2024 | 547.30 Mn |
| Jun 30, 2024 | 575.40 Mn |
| Jun 30, 2024 | 575.40 Mn |
| Mar 31, 2024 | 600.60 Mn |
| Mar 31, 2024 | 600.60 Mn |
| Dec 31, 2023 | 612.80 Mn |
| Dec 31, 2023 | 612.80 Mn |